BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30372544)

  • 1. Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy.
    Patel KA; Knight B; Aziz A; Babiker T; Tamar A; Findlay J; Cox S; Dimitropoulos I; Tysoe C; Panicker V; Vaidya B
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):328-333. PubMed ID: 30372544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of thyrotropin receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-thyrotropin receptor antibodies.
    Nishihara E; Fukata S; Hishinuma A; Amino N; Miyauchi A
    Thyroid; 2014 May; 24(5):789-95. PubMed ID: 24279482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N670S TSH receptor germline mutation masquerading as TSH receptor antibody negative Graves' disease.
    Schaarschmidt J; Paschke S; Özerden M; Jäschke H; Huth S; Eszlinger M; Meller J; Paschke R
    Horm Metab Res; 2012 Dec; 44(13):962-5. PubMed ID: 22763653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.
    Aycan Z; Ağladıoğlu SY; Ceylaner S; Cetinkaya S; Baş VN; Kendirici HN
    J Clin Res Pediatr Endocrinol; 2010; 2(4):168-72. PubMed ID: 21274318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism.
    Fuhrer D; Warner J; Sequeira M; Paschke R; Gregory J; Ludgate M
    Thyroid; 2000 Dec; 10(12):1035-41. PubMed ID: 11201847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of reduced in vivo surface expression of activating mutant thyrotrophin receptors in thyroid sections.
    Sequeira M; Jasani B; Fuhrer D; Wheeler M; Ludgate M
    Eur J Endocrinol; 2002 Feb; 146(2):163-71. PubMed ID: 11834424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
    Führer D; Wonerow P; Willgerodt H; Paschke R
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exceptional hyperthyroidism and a role for both major histocompatibility class I and class II genes in a murine model of Graves' disease.
    McLachlan SM; Aliesky HA; Chen CR; Williams RW; Rapoport B
    PLoS One; 2011; 6(6):e21378. PubMed ID: 21738647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity.
    Nishihara E; Chen CR; Higashiyama T; Mizutori-Sasai Y; Ito M; Kubota S; Amino N; Miyauchi A; Rapoport B
    Thyroid; 2010 Nov; 20(11):1307-14. PubMed ID: 20929407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
    Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
    Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-generation thyrotropin receptor antibodies assay and quantitative thyroid scintigraphy in autoimmune hyperthyroidism.
    Giovanella L; Ceriani L; Ghelfo A
    Horm Metab Res; 2008 Jul; 40(7):484-6. PubMed ID: 18393171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.
    Xia N; Ye X; Hu X; Song S; Xu H; Niu M; Wang H; Wang J
    PLoS One; 2017; 12(3):e0174260. PubMed ID: 28319174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
    Meller J; Jauho A; Hüfner M; Gratz S; Becker W
    Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease.
    Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Fiore E; Bucci I; Chamblin T; Vitti P; Monaco F; Napolitano G
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1106-15. PubMed ID: 22496495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
    Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
    J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal dominant nonautoimmune hyperthyroidism. Clinical features-diagnosis-therapy.
    Führer D; Mix M; Willgerodt H; Holzapfel HP; Von Petrykowski W; Wonerow P; Paschke R
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S10-5. PubMed ID: 9867189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor.
    Nagayama Y; Kita-Furuyama M; Ando T; Nakao K; Mizuguchi H; Hayakawa T; Eguchi K; Niwa M
    J Immunol; 2002 Mar; 168(6):2789-94. PubMed ID: 11884447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
    Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.